Loading...

Gregg Silverman

TitleSenate Emeritus
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9500 Gilman Drive #0663
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Lupus and the inhibitory dual receptor hypothesis
    NIH/NIAID R01AI090118Jun 7, 2010 - May 31, 2015
    Role: Principal Investigator
    alpha4beta1 Intergrin Signaling In Immunity And Arthritis
    NIH/NIAMS R01AR052367Jul 1, 2007 - May 31, 2012
    Role: Co-Principal Investigator
    Arthritis Research Conference 2007
    NIH/NIAMS R13AR055046Mar 1, 2007 - Aug 31, 2007
    Role: Principal Investigator
    Cell Death and Antibody-Mediated Protection from Autoimmunity
    NIH/NIAID R01AI068063Jul 15, 2006 - Jun 30, 2012
    Role: Principal Investigator
    Arthritis Research Conference 2005
    NIH/NIAMS R13AR052639Jun 1, 2005 - Aug 31, 2005
    Role: Principal Investigator
    BCR Mediated Apoptotic Death of Leukemia B Cells
    NIH/NCI R21CA104815Mar 9, 2004 - Feb 28, 2007
    Role: Principal Investigator
    Mechanisms to Induce Protective Natural Autoimmunity
    NIH/NIAMS R21AR050659Sep 26, 2003 - Jun 30, 2006
    Role: Principal Investigator
    RHEUMATIC DISEASES CORE CENTER
    NIH/NIAMS P30AR047360Sep 28, 2001 - Mar 31, 2008
    Role: Principal Investigator
    ENGINEERED B-CELL SUPERANTIGENS AND IMMUNE TOLERANCE
    NIH/NIAID R03AI046637Sep 30, 1999 - Aug 31, 2003
    Role: Principal Investigator
    B Cell Superantigens and Immune Regulation
    NIH/NIAID R01AI040305May 1, 1998 - Jan 31, 2010
    Role: Principal Investigator
    BACTERIAL B-CELL SUPERANTIGENS
    NIH/NIAID K02AI001378Jul 1, 1996 - Jun 30, 2001
    Role: Principal Investigator
    B CELL SUPERANTIGENS AND HUMAN IMMUNE REGULATION
    NIH/NIAID R29AI034001May 1, 1993 - Apr 30, 1998
    Role: Principal Investigator
    VARIABLE REGION GENE EXPRESSION IN HUMAN AUTOANTIBODIES
    NIH/NIAID K11AI000866May 1, 1988 - Apr 30, 1993
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Rosenbaum JT, Silverman G. The Microbiome and Systemic Lupus Erythematosus. N Engl J Med. 2018 06 07; 378(23):2236-2237. PMID: 29874543.
      View in: PubMed
    2. Silverman G, Azzouz DF, Mor A. Immune checkpoint inhibitors and the union of bugs against cancer. Kidney Int. 2018 May; 93(5):1030-1032. PMID: 29680016.
      View in: PubMed
    3. Pelzek AJ, Shopsin B, Radke EE, Tam K, Ueberheide BM, Fenyö D, Brown SM, Li Q, Rubin A, Fulmer Y, Chiang WK, Hernandez DN, El Bannoudi H, Sause WE, Sommerfield A, Thomsen IP, Miller AO, Torres VJ, Silverman G. Human Memory B Cells Targeting Staphylococcus aureus Exotoxins Are Prevalent with Skin and Soft Tissue Infection. MBio. 2018 Mar 13; 9(2). PMID: 29535203.
      View in: PubMed
    4. Hardt U, Larsson A, Gunnarsson I, Clancy RM, Petri M, Buyon JP, Silverman G, Svenungsson E, Grönwall C. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis. Arthritis Res Ther. 2018 Feb 26; 20(1):36. PMID: 29482604.
      View in: PubMed
    5. Azzouz DF, Silverman G. Is Gut Microbial LPS a Potential Trigger of Juvenile Idiopathic Arthritis? J Rheumatol. 2017 Nov; 44(11):1569-1571. PMID: 29093074.
      View in: PubMed
    6. Grönwall C, Hardt U, Gustafsson JT, Elvin K, Jensen-Urstad K, Kvarnström M, Grosso G, Rönnelid J, Padykov L, Gunnarsson I, Silverman G, Svenungsson E. Depressed serum IgM levels in SLE are restricted to defined subgroups. Clin Immunol. 2017 10; 183:304-315. PMID: 28919518.
      View in: PubMed
    7. Grönwall C, Amara K, Hardt U, Krishnamurthy A, Steen J, Engström M, Sun M, Ytterberg AJ, Zubarev RA, Scheel-Toellner D, Greenberg JD, Klareskog L, Catrina AI, Malmström V, Silverman G. Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis. J Autoimmun. 2017 Nov; 84:29-45. PMID: 28647488.
      View in: PubMed
    8. Sandigursky S, Silverman G, Mor A. Targeting the programmed cell death-1 pathway in rheumatoid arthritis. Autoimmun Rev. 2017 Aug; 16(8):767-773. PMID: 28572054.
      View in: PubMed
    9. Pelzek AJ, Grönwall C, Rosenthal P, Greenberg JD, McGeachy M, Moreland L, Rigby WFC, Silverman G. Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission. Arthritis Rheumatol. 2017 06; 69(6):1176-1186. PMID: 28118534.
      View in: PubMed
    10. El Bannoudi H, Anquetil C, Braunstein MJ, Pond SLK, Silverman G. Unbiased RACE-Based Massive Parallel Surveys of Human IgA Antibody Repertoires. Methods Mol Biol. 2017; 1643:45-73. PMID: 28667529.
      View in: PubMed
    11. Coffre M, Benhamou D, Rieß D, Blumenberg L, Snetkova V, Hines MJ, Chakraborty T, Bajwa S, Jensen K, Chong MMW, Getu L, Silverman G, Blelloch R, Littman DR, Calado D, Melamed D, Skok JA, Rajewsky K, Koralov SB. miRNAs Are Essential for the Regulation of the PI3K/AKT/FOXO Pathway and Receptor Editing during B Cell Maturation. Cell Rep. 2016 11 22; 17(9):2271-2285. PMID: 27880903.
      View in: PubMed
    12. Grönwall C, Clancy RM, Getu L, Lloyd KA, Siegel DL, Reed JH, Buyon JP, Silverman G. Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity. J Autoimmun. 2016 Sep; 73:30-41. PMID: 27289167; PMCID: PMC5003717 [Available on 09/01/17].
    13. Huck DM, Okello E, Mirembe G, Ssinabulya I, Zidar DA, Silverman G, Getu L, Nowacki AS, Calabrese LH, Salata RA, Longenecker CT. Role of Natural Autoantibodies in Ugandans With Rheumatic Heart Disease and HIV. EBioMedicine. 2016 Mar; 5:161-6. PMID: 27077123; PMCID: PMC4816839.
    14. Challener GJ, Jones JD, Pelzek AJ, Hamilton BJ, Boire G, de Brum-Fernandes AJ, Masetto A, Carrier N, Ménard HA, Silverman G, Rigby WFC. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis. J Rheumatol. 2016 Feb; 43(2):273-281. PMID: 26669911; PMCID: PMC4737983 [Available on 02/01/17].
    15. Frost SD, Murrell B, Hossain AS, Silverman G, Pond SL. Assigning and visualizing germline genes in antibody repertoires. Philos Trans R Soc Lond B Biol Sci. 2015 Sep 05; 370(1676). PMID: 26194754; PMCID: PMC4528417.
    16. Peled M, Strazza M, Azoulay-Alfaguter I, Silverman G, Scher JU, Mor A. Erratum to: Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis. Inflammation. 2015 Aug; 38(4):1580. PMID: 25847627.
      View in: PubMed
    17. Peled M, Strazza M, Azoulay-Alfaguter I, Silverman G, Scher JU, Mor A. Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis. Inflammation. 2015 Aug; 38(4):1573-9. PMID: 25663558.
      View in: PubMed
    18. Genovese MC, Silverman G, Emery P, Gupta RC, Gill A, Veenhuizen M, Xie L, Komocsar WJ, Berclaz PY, Lee C. Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O). J Clin Rheumatol. 2015 Aug; 21(5):231-8. PMID: 26203826.
      View in: PubMed
    19. Silverman G. Protective natural autoantibodies to apoptotic cells: evidence of convergent selection of recurrent innate-like clones. Ann N Y Acad Sci. 2015 Dec; 1362:164-75. PMID: 25990717.
      View in: PubMed
    20. Strazza M, Azoulay-Alfaguter I, Silverman G, Mor A. T cell chemokine receptor patterns as pathogenic signatures in autoimmunity. Discov Med. 2015 Feb; 19(103):117-25. PMID: 25725226.
      View in: PubMed
    21. Pedoeem A, Azoulay-Alfaguter I, Strazza M, Silverman G, Mor A. Programmed death-1 pathway in cancer and autoimmunity. Clin Immunol. 2014 Jul; 153(1):145-52. PMID: 24780173.
      View in: PubMed
    22. Grönwall C, Charles ED, Dustin LB, Rader C, Silverman G. Selection of apoptotic cell specific human antibodies from adult bone marrow. PLoS One. 2014; 9(4):e95999. PMID: 24760047; PMCID: PMC3997490.
    23. Grönwall C, Reynolds H, Kim JK, Buyon J, Goldberg JD, Clancy RM, Silverman G. Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus. Clin Immunol. 2014 Jul; 153(1):1-7. PMID: 24704464; PMCID: PMC4068957.
    24. Grönwall C, Silverman G. Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease. J Clin Immunol. 2014 Jul; 34 Suppl 1:S12-21. PMID: 24691998; PMCID: PMC4354681.
    25. Silverman G, Pelzek A. Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responses. J Rheumatol. 2014 May; 41(5):825-8. PMID: 24692519; PMCID: PMC4386843.
    26. Silverman G, Vas J, Grönwall C. Protective autoantibodies in the rheumatic diseases: lessons for therapy. Nat Rev Rheumatol. 2013 May; 9(5):291-300. PMID: 23507902.
      View in: PubMed
    27. Vas J, Grönwall C, Silverman G. Fundamental roles of the innate-like repertoire of natural antibodies in immune homeostasis. Front Immunol. 2013; 4:4. PMID: 23386848; PMCID: PMC3564042.
    28. Grönwall C, Chen Y, Vas J, Khanna S, Thiel S, Corr M, Kono DH, Silverman G. MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses. Proc Natl Acad Sci U S A. 2012 Nov 27; 109(48):19745-50. PMID: 23139409; PMCID: PMC3511709.
    29. Vas J, Grönwall C, Marshak-Rothstein A, Silverman G. Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes. Arthritis Rheum. 2012 Oct; 64(10):3388-98. PMID: 22577035; PMCID: PMC3462267.
    30. Grönwall C, Kosakovsky Pond SL, Young JA, Silverman G. In vivo VL-targeted microbial superantigen induced global shifts in the B cell repertoire. J Immunol. 2012 Jul 15; 189(2):850-9. PMID: 22696444; PMCID: PMC3598568.
    31. Grönwall C, Vas J, Silverman G. Protective Roles of Natural IgM Antibodies. Front Immunol. 2012; 3:66. PMID: 22566947; PMCID: PMC3341951.
    32. Kaveri SV, Silverman G, Bayry J. Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol. 2012 Feb 01; 188(3):939-45. PMID: 22262757; PMCID: PMC3266110.
    33. Grönwall C, Akhter E, Oh C, Burlingame RW, Petri M, Silverman G. IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Clin Immunol. 2012 Mar; 142(3):390-8. PMID: 22297166; PMCID: PMC3632049.
    34. Elkon KB, Silverman G. Naturally occurring autoantibodies to apoptotic cells. Adv Exp Med Biol. 2012; 750:14-26. PMID: 22903663.
      View in: PubMed
    35. Lal P, Su Z, Holweg CT, Silverman G, Schwartzman S, Kelman A, Read S, Spaniolo G, Monroe JG, Behrens TW, Townsend MJ. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis Rheum. 2011 Dec; 63(12):3681-91. PMID: 22127691.
      View in: PubMed
    36. MacLellan LM, Montgomery J, Sugiyama F, Kitson SM, Thümmler K, Silverman G, Beers SA, Nibbs RJ, McInnes IB, Goodyear CS. Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice. Arthritis Rheum. 2011 Dec; 63(12):3897-907. PMID: 22127707; PMCID: PMC3598489.
    37. Becker-Herman S, Meyer-Bahlburg A, Schwartz MA, Jackson SW, Hudkins KL, Liu C, Sather BD, Khim S, Liggitt D, Song W, Silverman G, Alpers CE, Rawlings DJ. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J Exp Med. 2011 Sep 26; 208(10):2033-42. PMID: 21875954; PMCID: PMC3182055.
    38. Bartok B, Silverman G. Development of anti-CD20 therapy for multiple sclerosis. Exp Cell Res. 2011 May 15; 317(9):1312-8. PMID: 21510932; PMCID: PMC3266104.
    39. Silverman G. Regulatory natural autoantibodies to apoptotic cells: pallbearers and protectors. Arthritis Rheum. 2011 Mar; 63(3):597-602. PMID: 21360488; PMCID: PMC3056121.
    40. Silverman G. Rethinking the red wolf disease: does Protein S suppress systemic lupus erythematosus clinical activity? Arthritis Res Ther. 2010; 12(5):144. PMID: 21067626; PMCID: PMC2991027.
    41. Silverman G, Grönwall C, Vas J, Chen Y. Natural autoantibodies to apoptotic cell membranes regulate fundamental innate immune functions and suppress inflammation. Discov Med. 2009 Oct; 8(42):151-6. PMID: 19833064.
      View in: PubMed
    42. Kono DH, Haraldsson MK, Lawson BR, Pollard KM, Koh YT, Du X, Arnold CN, Baccala R, Silverman G, Beutler BA, Theofilopoulos AN. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci U S A. 2009 Jul 21; 106(29):12061-6. PMID: 19574451; PMCID: PMC2715524.
    43. Chen Y, Khanna S, Goodyear CS, Park YB, Raz E, Thiel S, Grönwall C, Vas J, Boyle DL, Corr M, Kono DH, Silverman G. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol. 2009 Jul 15; 183(2):1346-59. PMID: 19564341; PMCID: PMC2713016.
    44. Chen Y, Park YB, Patel E, Silverman G. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol. 2009 May 15; 182(10):6031-43. PMID: 19414754; PMCID: PMC4428684.
    45. Kulik L, Fleming SD, Moratz C, Reuter JW, Novikov A, Chen K, Andrews KA, Markaryan A, Quigg RJ, Silverman G, Tsokos GC, Holers VM. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J Immunol. 2009 May 01; 182(9):5363-73. PMID: 19380783; PMCID: PMC2820395.
    46. Catera R, Silverman G, Hatzi K, Seiler T, Didier S, Zhang L, Hervé M, Meffre E, Oscier DG, Vlassara H, Scofield RH, Chen Y, Allen SL, Kolitz J, Rai KR, Chu CC, Chiorazzi N. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med. 2008 Nov-Dec; 14(11-12):665-74. PMID: 19009014; PMCID: PMC2582860.
    47. Goodyear CS, Silverman G. Phage-display methodology for the study of protein-protein interactions: stage 2, panning. CSH Protoc. 2008 Aug 01; 2008:pdb.prot5021. PMID: 21356887.
      View in: PubMed
    48. Goodyear CS, Silverman G. Phage-display methodology for the study of protein-protein interactions: overview. CSH Protoc. 2008 Aug 01; 2008:pdb.top48. PMID: 21356898.
      View in: PubMed
    49. Goodyear CS, Silverman G. Phage-display methodology for the study of protein-protein interactions: stage 1, generating libraries. CSH Protoc. 2008 Aug 01; 2008:pdb.prot5020. PMID: 21356886.
      View in: PubMed
    50. Goodyear CS, Silverman G. Phage-display methodology for the study of protein-protein interactions: stage 3, binding analysis. CSH Protoc. 2008 Aug 01; 2008:pdb.prot5022. PMID: 21356888.
      View in: PubMed
    51. Silverman G, Boyle DL. Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesis. Immunol Rev. 2008 Jun; 223:175-85. PMID: 18613836.
      View in: PubMed
    52. Silverman G, Srikrishnan R, Germar K, Goodyear CS, Andrews KA, Ginzler EM, Tsao BP. Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin Exp Immunol. 2008 Jul; 153(1):102-16. PMID: 18510544; PMCID: PMC2432104.
    53. Silverman G, Linnik MD. Therapeutic potential (2). Lupus. 2008 Mar; 17(3):262-5. PMID: 18372374.
      View in: PubMed
    54. Barbas CF, Burton DR, Scott JK, Silverman G. Quantitation of DNA and RNA. CSH Protoc. 2007 Nov 01; 2007:pdb.ip47. PMID: 21356961.
      View in: PubMed
    55. Silverman G, Khanna S. B cell modulation in rheumatology. Curr Opin Pharmacol. 2007 Aug; 7(4):426-33. PMID: 17625968; PMCID: PMC2693398.
    56. Goodyear CS, Corr M, Sugiyama F, Boyle DL, Silverman G. Cutting Edge: Bim is required for superantigen-mediated B cell death. J Immunol. 2007 Mar 01; 178(5):2636-40. PMID: 17312102.
      View in: PubMed
    57. Silverman G. Anti-CD20 therapy and autoimmune disease: therapeutic opportunities and evolving insights. Front Biosci. 2007 Jan 01; 12:2194-206. PMID: 17127456.
      View in: PubMed
    58. O'Seaghdha M, van Schooten CJ, Kerrigan SW, Emsley J, Silverman G, Cox D, Lenting PJ, Foster TJ. Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. FEBS J. 2006 Nov; 273(21):4831-41. PMID: 16999823.
      View in: PubMed
    59. Enzler T, Bonizzi G, Silverman G, Otero DC, Widhopf GF, Anzelon-Mills A, Rickert RC, Karin M. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity. 2006 Sep; 25(3):403-15. PMID: 16973390.
      View in: PubMed
    60. Silverman G. Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms. Arthritis Rheum. 2006 Aug; 54(8):2356-67. PMID: 16868991.
      View in: PubMed
    61. Silverman G, Goodyear CS. Confounding B-cell defences: lessons from a staphylococcal superantigen. Nat Rev Immunol. 2006 Jun; 6(6):465-75. PMID: 16724100.
      View in: PubMed
    62. Goodyear CS, Sugiyama F, Silverman G. Temporal and dose-dependent relationships between in vivo B cell receptor-targeted proliferation and deletion-induced by a microbial B cell toxin. J Immunol. 2006 Feb 15; 176(4):2262-71. PMID: 16455982.
      View in: PubMed
    63. Féral CC, Rose DM, Han J, Fox N, Silverman G, Kaushansky K, Ginsberg MH. Blocking the alpha 4 integrin-paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site. J Clin Invest. 2006 Mar; 116(3):715-23. PMID: 16470243; PMCID: PMC1361348.
    64. Rodriguez W, Mold C, Marnell LL, Hutt J, Silverman G, Tran D, Du Clos TW. Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. Arthritis Rheum. 2006 Jan; 54(1):325-35. PMID: 16385552.
      View in: PubMed
    65. Silverman G. Targeting of B cells in SLE: rationale and therapeutic opportunities. Bull NYU Hosp Jt Dis. 2006; 64(1-2):51-6. PMID: 17121490.
      View in: PubMed
    66. Cappione A, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, Silverman G, Sanz I. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest. 2005 Nov; 115(11):3205-16. PMID: 16211091; PMCID: PMC1242189.
    67. Palmqvist N, Silverman G, Josefsson E, Tarkowski A. Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus. Microbes Infect. 2005 Dec; 7(15):1501-11. PMID: 16039897.
      View in: PubMed
    68. Goodyear CS, Silverman G. B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies. Springer Semin Immunopathol. 2005 Mar; 26(4):463-84. PMID: 15633015.
      View in: PubMed
    69. Binder CJ, Silverman G. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol. 2005 Mar; 26(4):385-404. PMID: 15609021.
      View in: PubMed
    70. Silverman G. Anti-CD20 therapy in systemic lupus erythematosus: a step closer to the clinic. Arthritis Rheum. 2005 Feb; 52(2):371-7. PMID: 15692969.
      View in: PubMed
    71. Silverman G, Goodyear CS, Siegel DL. On the mechanism of staphylococcal protein A immunomodulation. Transfusion. 2005 Feb; 45(2):274-80. PMID: 15660839.
      View in: PubMed
    72. Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman G, Berliner JA, Witztum JL. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med. 2004 Dec 06; 200(11):1359-70. PMID: 15583011; PMCID: PMC2211955.
    73. Goodyear CS, Silverman G. Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. Proc Natl Acad Sci U S A. 2004 Aug 03; 101(31):11392-7. PMID: 15273292; PMCID: PMC509211.
    74. Meyer M, Belke DD, Trost SU, Swanson E, Dieterle T, Scott B, Cary SP, Ho P, Bluhm WF, McDonough PM, Silverman G, Dillmann WH. A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation. FASEB J. 2004 Aug; 18(11):1312-4. PMID: 15180962.
      View in: PubMed
    75. Goodyear CS, Narita M, Silverman G. In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin. J Immunol. 2004 Mar 01; 172(5):2870-7. PMID: 14978088.
      View in: PubMed
    76. Silverman G, Carson DA. Roles of B cells in rheumatoid arthritis. Arthritis Res Ther. 2003; 5 Suppl 4:S1-6. PMID: 15180890; PMCID: PMC2833442.
    77. Shaw PX, Goodyear CS, Chang MK, Witztum JL, Silverman G. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J Immunol. 2003 Jun 15; 170(12):6151-7. PMID: 12794145.
      View in: PubMed
    78. Silverman G, Weisman S. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum. 2003 Jun; 48(6):1484-92. PMID: 12794814.
      View in: PubMed
    79. Binder CJ, Hörkkö S, Dewan A, Chang MK, Kieu EP, Goodyear CS, Shaw PX, Palinski W, Witztum JL, Silverman G. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med. 2003 Jun; 9(6):736-43. PMID: 12740573.
      View in: PubMed
    80. Goodyear CS, Silverman G. Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin. J Exp Med. 2003 May 05; 197(9):1125-39. PMID: 12719481; PMCID: PMC2193973.
    81. Berry JD, Rutherford J, Silverman G, Kaul R, Elia M, Gobuty S, Fuller R, Plummer FA, Barbas CF. Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from human cervical B cells. Hybrid Hybridomics. 2003 Apr; 22(2):97-108. PMID: 12831535.
      View in: PubMed
    82. Scamurra RW, Nelson DB, Lin XM, Miller DJ, Silverman G, Kappel T, Thurn JR, Lorenz E, Kulkarni-Narla A, Janoff EN. Mucosal plasma cell repertoire during HIV-1 infection. J Immunol. 2002 Oct 01; 169(7):4008-16. PMID: 12244203.
      View in: PubMed
    83. Silverman G, Goodyear CS. A model B-cell superantigen and the immunobiology of B lymphocytes. Clin Immunol. 2002 Feb; 102(2):117-34. PMID: 11846453.
      View in: PubMed
    84. Silverman G. Adoptive transfer of a superantigen-induced hole in the repertoire of natural IgM-secreting cells. Cell Immunol. 2001 Apr 10; 209(1):76-80. PMID: 11414738.
      View in: PubMed
    85. Silverman G, Cary SP, Dwyer DC, Luo L, Wagenknecht R, Curtiss VE. A B cell superantigen-induced persistent "Hole" in the B-1 repertoire. J Exp Med. 2000 Jul 03; 192(1):87-98. PMID: 10880529; PMCID: PMC1887708.
    86. Silverman G, Nayak JV, Warnatz K, Hajjar FF, Cary S, Tighe H, Curtiss VE. The dual phases of the response to neonatal exposure to a VH family-restricted staphylococcal B cell superantigen. J Immunol. 1998 Nov 15; 161(10):5720-32. PMID: 9820554.
      View in: PubMed
    87. Silverman G. B-cell superantigens. Immunol Today. 1997 Aug; 18(8):379-86. PMID: 9267080.
      View in: PubMed
    88. Silverman G, Nayak JV, La Cava A. B-cell superantigens: molecular and cellular implications. Int Rev Immunol. 1997; 14(4):259-90. PMID: 9186781.
      View in: PubMed
    Gregg's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _